
1001 - 5000 funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
Pharmaceuticals • Healthcare • Biotechnology
As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.
🕒 Setembro 22
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $186.489 - $278.875 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 7%
🗣️🇺🇸🇬🇧 Inglês obrigatório
De onde vem esta vaga
Publicada na página de carreiras da Otsuka Pharmaceutical Companies (U.S.) ↗, não em um site de vagas
Vista pela primeira vez pelo Remote Rocketship Setembro 22
Ainda aberta no site da Otsuka Pharmaceutical Companies (U.S.). Verificada 5 horas atrás.

1001 - 5000 funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
Pharmaceuticals • Healthcare • Biotechnology
As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.
• Lead strategy and programs reducing barriers to disease recognition, specialist referral, diagnosis, genetic testing and counseling, and connection to specialty care • Lead compliant, unbranded disease education and diagnostic-pathway readiness before approval • Lead branded patient and caregiver marketing following approval • Partner with Patient Services on support-experience and persistence programs using aggregate, deidentified data • Own omnichannel strategy and execution for unbranded market-development and disease-education programs and, following approval, branded patient and caregiver programs • Establish shared audience-journey frameworks, channel-orchestration standards, marketing-technology and data requirements, and measurement approaches • Lead development, execution, and measurement of unbranded HCP disease-state peer-to-peer programs • Build symptom- and pathway-oriented education for patients, caregivers, and clinicians • Define commercial requirements for genetic-testing access programs • Own the annual plan, budget, agency and vendor execution, and aggregate performance measures • Serve as primary marketing liaison to the Omnichannel Business Partner • Co-lead the advertising Agency of Record relationship • Identify recurring system-level barriers using research, advocacy insights, and aggregate data • Lead commercial responses to recurring genetic-testing, specialist-referral, treatment-center connection, and support barriers • Lead or support patient and caregiver advisory boards • Partner with advocacy organizations to extend education, referral, and support resources • Coordinate with National Patient Advocacy on strategy, funding governance, and content independence • Partner with Medical Affairs, Market Access, HUB/Patient Services, TLL, Account Managers, and Brand Strategy & HCP Engagement • Set national market-development and patient-journey priorities and equip field teams with approved programs and aggregate insights • Contribute to congress strategy and cross-functional launch planning
• At least 10 years of commercial experience in the U.S. biopharmaceutical industry • Experience including market development, disease education, patient marketing, digital and omnichannel engagement, new-product launches, and market analysis • Recent rare disease commercialization experience required • Demonstrated pre-launch experience building compliant unbranded education and pathway programs • Post-approval patient marketing experience • Demonstrated success partnering with patient advocacy organizations under appropriate governance • Diagnostics, genetics, neurology, or diagnostic-pathway market development strongly preferred • MBA or relevant graduate degree preferred • Up to 30% travel based on business needs
• Incentive opportunity • Comprehensive medical, dental, vision, and prescription drug coverage • Company-provided basic life insurance • Accidental death and dismemberment insurance • Short-term and long-term disability insurance • Tuition reimbursement • Student loan assistance • Generous 401(k) match • Flexible time off • Paid holidays • Paid leave programs • Other company-provided benefits
Candidatar-seMelhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.
🕒 Setembro 22
Commercial Director leading US enterprise sales for Neara’s AI-powered electricity-grid digital twins. Managing Account Executives, regional revenue, forecasting, strategic accounts, and customer growth.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $225.000 / ano
💰 Series B em 2022-05
⏰ Tempo Integral
🟠 Sênior
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 22
Senior technology leader delivering clinical IT solutions for U.S. Anesthesia Partners, a nationwide anesthesia practice. Overseeing application development, automation, platforms, support, vendors, and technical teams.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 22
Health Systems Director advancing hospital access and sales for Sobi’s rare-disease therapies. Managing health-system stakeholders, formulary pathways, clinical education, and account plans in North Texas.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $180.000 - $220.000 / ano
⏰ Tempo Integral
🟠 Sênior
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 22
Operational efficiency director improving technology and processes for Strongpoint Partners’ retirement plan administration platform. Leading system migrations, adoption, and scalable straight-through processing.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 22
Director leading field execution, national meetings, and cross-functional programs for Madrigal’s MASH therapeutics commercialization. Driving field readiness, adoption, process improvement, budgets, and vendor performance.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $259.000.000 Post-IPO Equity em 2022-12
⏰ Tempo Integral
🟠 Sênior
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório